Involvement of ERK phosphorylation in the prevention of ischemia-induced ovarian follicular depletion by stem cells

Chinese Journal of Physiology

Volumn 53, Issue 3, 2010, Pages 167-177

  Tsai, Shiow Chwen ^a   Chen, Chie Pein ^c   Su, Tsung Hsien ^b   Kau, Mei Mei ^d   Lu, Chien Chen ^b,c  

^a UNIVERSITY OF TAIPEI   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

Author keywords

ERK; Ischemia; Ovary; Rat; Stem cell

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 SIDE CHAIN CLEAVAGE ENZYME; ESTRADIOL; GONADOTROPIN; LUTEINIZING HORMONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROGESTERONE; STEROIDOGENIC ACUTE REGULATORY PROTEIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; GRANULOSA CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIA; NONHUMAN; ORGAN SIZE; ORGAN WEIGHT; OVARY DISEASE; OVARY FOLLICLE DEPLETION; OVARY FOLLICLE DEVELOPMENT; PREGNANCY; PROTEIN EXPRESSION; RAT; STEM CELL TRANSPLANTATION; THECA CELL; VASCULAR ENDOTHELIUM;

EID: 78149441905     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2010.AMK027     Document Type: Article

References (41)

1. Betterle, C., Coco, G. and Zanchetta, R. Adrenal cortex autoantibodies in subjects with normal adrenal function. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 19: 85-99, 2005.
2. Blumenfeld, Z. and Haim, N. Prevention of gonadal damage during cytotoxic therapy. Ann. Med. 29: 199-206, 1997.
3. Brown, L. and Benchimol, S. The involvement of MAPK signaling pathways in determining the cellular response to p53 activation: cell cycle arrest or apoptosis. J. Biol. Chem. 281: 3832-3840, 2006.
4. Bukovsky, A., Caudle, M.R., Svetlikova, M., Wimalasena, J., Ayala, M.E. and Dominguez, R. Oogenesis in adult mammals, including humans: a review. Endocrine 26: 301-316, 2005.
5. Callejo, J., Vilaseca, S., Medina, M., Salvador, C., Valls, C. and Lailla, J.M. Inhibin and follicular development in heterotopical ovary transplants without vascular pedicle in syngeneic Lewis rats. Fertil. Steril. 79 Suppl 1: 743-748, 2003.
6. Cameron, M.R., Foster, J.S., Bukovsky, A. and Wimalasena, J. Activation of mitogen-activated protein kinases by gonadotropins and cyclic adenosine 5'-monophosphates in porcine granulosa cells. Biol. Reprod. 55: 111-119, 1996.
7. Celik, O., Turkoz, Y., Hascalik, S., Hascalik, M., Cigremis, Y., Mizrak, B. and Yologlu, S. The protective effect of caffeic acid phenethyl ester on ischemia-reperfusion injury in rat ovary. Eur. J. Obstet. Gynecol. Reprod. Biol. 117: 183-188, 2004.
8. Chin, C.H., Wu, L.S. and Jong, D.S. Production and application of a polyclonal peptide antiserum for universal detection of StAR protein. Chinese J. Physiol. 51: 54-61, 2008.
9. Das, S., Maizels, E.T., DeManno, D., St. Clair, E., Adam, S.A. and Hunzicker-Dunn, M. A stimulatory role of cyclic adenosine 3', 5'-monophosphate in follicle-stimulating hormone-activated mitogen-activated protein kinase signaling pathway in rat ovarian granulosa cells. Endocrinology 137: 967-974, 1996.
10. Fimiani, G., Laperuta, C., Falco, G., Ventruto, V., D'Urso, M., Ursini, M.V. and Miano, M.G. Heterozygosity mapping by quantitative fluorescent PCR reveals an interstitial deletion in Xq26.2-q28 associated with ovarian dysfunction. Hum. Reprod. 21: 529-535, 2006.
11. Fu, X., He, Y., Xie, C. and Liu, W. Bone marrow mesenchymal stem cell transplantation improves ovarian function and structure in rats with chemotherapy-induced ovarian damage. Cytotherapy 10: 353-363, 2008.
12. Hakuba, N., Hata, R., Morizane, I., Feng, G., Shimizu, Y., Fujita, K., Yoshida, T., Sakanaka, M. and Gyo, K. Neural stem cells suppress the hearing threshold shift caused by cochlear ischemia. Neuroreport 16: 1545-1549, 2005.
13. i , and MAPKs phosphorylation of OC2 human oral cancer cells. Chinese J. Physiol. 52: 128-135, 2009.
14. Johnson, J., Bagley, J., Skaznik-Wikiel, M., Lee, H.-J., Adams, G.B., Niikura, Y., Tschudy, K.S., Tilly, J.C., Cortes, M.L., Forkert, R., Spitzer, T., Iacomini, J., Scadden, D.T. and Tilly, J.L. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell 122: 303-315, 2005.
15. Kagawa, N., Kuwayama, M., Miyano, T. and Manabe, N. Growth and maturation of follicles and oocytes following xenotransplantation of porcine ovarian tissues and in vitro maturation. J. Reprod. Develop. 51: 741-748, 2005.
16. Kao, C.F., Chuang, C.Y., Chen, C.H. and Kuo, H.C. Human pluripotent stem cells: current status and future perspectives. Chinese J. Physiol. 51: 214-225, 2008.
17. Lee, H.-J., Selesniemi, K., Niikura, Y., Niikura, T., Klein, R., Dombkowski, D.M. and Tilly, J.L. Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure. J. Clin. Oncol. 25: 3198-3204, 2007.
18. Leung, W.K., Wu, Q., Hannam, P.M., McBride, B.C. and Uitto, V.-J. Treponema denticola may stimulate both epithelial proliferation and apoptosis through MAP kinase signal pathways. J. Periodontal. Res. 37: 445-455, 2002.
19. Lin, T.C. and Lee, O.K. Stem cells: a primer. Chinese J. Physiol. 51: 197-207, 2008.
20. Lunenfeld, E., Schwartz, I., Meizner, I., Potashnik, G. and Glezerman, M. Intraovarian blood flow during spontaneous and stimulated cycles. Hum. Reprod. 11: 2481-2483, 1996.
21. Makkar, R.R., Price, M.J., Lill, M., Frantzen, M., Takizawa, K., Kleisli, T., Zheng, J., Kar, S., McClelan, R., Miyamota, T., Bick-Forrester, J., Fishbein, M.C., Shah, P.K., Forrester, J.S., Sharifi, B., Chen, P.-S. and Qayyum, M. Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction. J. Cardiovasc. Pharmacol. Ther. 10: 225-233, 2005.
22. Meirow, D., Assad, G., Dor, J. and Rabinovici, J. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice. Hum. Reprod. 19: 1294-1299, 2004.
23. Miller, W.L. Minireview: regulation of steroidogenesis by electron transfer. Endocrinology 146: 2544-2550, 2005.
24. Miller, W.L. Molecular biology of steroid hormone synthesis. Endocr. Rev. 9: 295-318, 1988.
25. Mlcochova, H., Horejsi, J., Martinek, J., Vetesnikova-Koubova, R. and Halaska, M. Treatment of autoimunne ovarian damage in adolescent girls. Neuroendocrinol. Lett. 26: 131-135, 2005.
26. Monnier-Barbarino, P., Forges, T., Faure, G.C. and Bene, M.C. Ovarian autoimmunity and ovarian pathologies: antigenic targets and diagnostic significance. J. Gynecol. Obstet. Biol. Reprod. (Paris) 34: 649-657, 2005.
27. Okamoto, T., Aoyama, T., Nakayama, T., Nakamata, T., Hosaka, T., Nishijo, K., Nakamura, T., Kiyono, T. and Toguchida, J. Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochem. Biophys. Res. Commun. 295: 354-361, 2002.
28. Payne, A.H. and Hales, D.B. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr. Rev. 25: 947-970, 2004.
29. Russell, J.M., Murphree, E., Janik, J. and Callahan, P. Effect of steroids and nitric oxide on pituitary hormone release in ovariectomized, peripubertal rats. Reproduction 129: 497-504, 2005.
30. Seger, R., Hanoch, T., Rosenberg, R., Dantes, A., Merz, W.E., Strauss, J.F., III and Amsterdam, A. The ERK signaling cascade inhibits gonadotropin-stimulated steroidogenesis. J. Biol. Chem. 276: 13957-13964, 2001.
31. Sierra, A. Neurosteroids: the StAR protein in the brain. J. Neuroendocrinol. 16: 787-793, 2004.
32. Silber, S.J., Lenahan, K.M., Levine, D.J., Pineda, J.A., Gorman, K.S., Friez, M.J., Crawford, E.C. and Gosden, R.G. Ovarian transplantation between monozygotic twins discordant for premature ovarian failure. N. Engl. J. Med. 353: 58-63, 2005.
33. Sklar, C. Maintenance of ovarian function and risk of premature menopause related to cancer treatment. J. Natl. Cancer Inst. Monogr. 34: 25-27, 2005.
34. Stocco, D.M. Tracking the role of a StAR in the sky of the new millennium. Mol. Endocrinol. 15: 1245-1254, 2001.
35. Tan, S.L., Zaidi, J., Campbell, S., Doyle, P. and Collins, W. Blood flow changes in the ovarian and uterine arteries during the normal menstrual cycle. Am. J. Obstet. Gynecol. 175: 625-631, 1996.
36. Tonacchera, M., Ferrarini, E., Dimida, A., Agretti, P., De Marco, G., De Servi, M., Gianetti, E., Chiovato, L., Pucci, E., Pra, C.D., Betterle, C., Aghini-Lombardi, F., Vitti, P. and Pinchera, A. Gonadotrophin receptor blocking antibodies measured by the use of cell lines stably expressing human gonadotrophin receptors are not detectable in women with 46,XX premature ovarian failure. Clin. Endocrinol. (Oxf) 61: 376-381, 2004.
37. Turkoz, Y., Celik, O., Hascalik, S., Cigremis, Y., Hascalik, M., Mizrak, B. and Yologlu, S. Melatonin reduces torsion-detorsion injury in rat ovary: biochemical and histopathologic evaluation. J. Pineal Res. 37: 137-141, 2004.
38. Uguralp, S., Bay Karabulut, A. and Mizrak, B. Effects of pentoxifylline and vitamin E on the bilateral ovary after experimental ovarian ischemia. Eur. J. Pediatr. Surg. 15: 107-113, 2005.
39. Welt, C.K., Hall, J.E., Adams, J.M. and Taylor, A.E. Relationship of estradiol and inhibin to the follicle-stimulating hormone variability in hypergonadotropic hypogonadism or premature ovarian failure. J. Clin. Endocrinol. Metab. 90: 826-830, 2005.
40. Wollert, K.C. and Drexler, H. Clinical applications of stem cells for the heart. Circ. Res. 96: 151-163, 2005.
41. Xu, C., Shen, G., Yuan, X., Kim, J.-H., Gopalkrishnan, A., Keum, Y.-S., Nair, S. and Kong, A.-N.T. ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. Carcinogenesis 27: 437-445, 2006.